Art

J-GLOBAL ID：202202232573897486   Reference number：22A1880421

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review

限定治療選択肢によるPseudomonas aeruginosa感染治療のための新しい薬剤:物語レビュー【JST・京大機械翻訳】

Author (5)： Losito Angela Raffaella (Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy) ,  Raffaelli Francesca (Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy) ,  Giacomo Paola Del (Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy) ,  Tumbarello Mario (Dipartimento di Biotecnologie Mediche, Universita degli Studi di Siena, 53100 Siena, Italy) ,  Tumbarello Mario (UOC Malattie Infettive e Tropicali, Azienda Ospedaliero Universitaria Senese, 53100 Siena, Italy)
Material： Antibiotics (Web)
Volume： 11  Issue： 5  Page： 579  Publication year： 2022 
JST Material Number： U7132A  ISSN： 2079-6382  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： P. aeruginosa is still one of ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1880421&from=J-GLOBAL&jstjournalNo=U7132A") }}

Thesaurus term： antibacterial drug ,  antibiotics ,  *infection ,  *Pseudomonas aeruginosa ,  *Pseudomonas ,  clinical medicine ,  pathogen ,  epidemiology ,  *therapy ,  porin ,  hospital infection ,  beta-lactamase ,  carboxylic acid ,  lactam
Semi thesaurus term： 排出ポンプ ,  分離株 , 【Automatic Indexing@JST】

Author keywords (8)： Pseudomonas aeruginosa ,  difficult-to-treat resistant (DTR) ,  new β-lactam-β-lactamase inhibitor combinations ,  cefiderocol ,  imipenem-cilastatin-relebactam ,  meropenem-vaborbactam ,  plazomicin ,  fosfomycin combination strategy

JST classification (1)： Infectious diseases,parasitics diseases in general.  (GD01010H)

Substance index (1)： Carbapenem

Reference (149)：

• Moradali, M.F.; Ghods, S.; Rehm, B.H. Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front. Cell. Infect. Microbiol. 2017, 7, 39.
• Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268-281.
• Kadri, S.S.; Adjemian, J.; Lai, Y.L.; Spaulding, A.B.; Ricotta, E.; Prevots, D.R.; Palmore, T.N.; Rhee, C.; Klompas, M.; Dekker, J.P.; et al. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin. Infect. Dis. 2018, 67, 1803-1814.
• Behzadi, P.; Baráth, Z.; Gajdács, M. It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 2021, 10, 42.
• WHO World Health Organization. Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed on 30 March 2022). Healthcare-Associated Infections Acquired in Intensive Care Units. Annual Epidemiological Report for 2017; European Centre for Disease Prevention and Control: Stockholm, Sweden, 2019; Available online: https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-intensive-care-units-annual-epidemiological-1 (accessed on 30 March 2022).

Terms in the title (7)： 治療選択肢 ,  Pseudomonas ,  感染 ,  治療 ,  薬剤 ,  物語 ,  レビュー